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In maxillofacial and oral surgery, there is a need for the development of tissue-engineered constructs. They are
used for reconstructions due to trauma, dental implants, congenital defects, or oral cancer. A noninvasive
monitoring of the fabrication of tissue-engineered constructs at the production and implantation stages done in
real time is extremely important for predicting the success of tissue-engineered grafts. We demonstrated a
Raman spectroscopic probe system, its design and application, for real-time ex vivo produced oral mucosa
equivalent (EVPOME) constructs noninvasive monitoring. We performed in vivo studies to find Raman
spectroscopic indicators for postimplanted EVPOME failure and determined that Raman spectra of EVPOMEs
preexposed to thermal stress during manufacturing procedures displayed correlation of the band height ratio of
CH2 deformation to phenylalanine ring breathing modes, giving a Raman metric to distinguish between healthy
and compromised postimplanted constructs. This study is the step toward our ultimate goal to develop a stand-
alone system, to be used in a clinical setting, where the data collection and analysis are conducted on the basis
of these spectroscopic indicators with minimal user intervention.
Introduction
T issue-engineered oral mucosa is being used forseveral applications, including clinical transplantation,
in vitro models for cell–cell and cell–material interactions,
and study of cancer and normal tissue.1 Mucosal grafts are
essential for clinical applications in oral and maxillofacial
surgery, including dental implants, preprosthetic surgery,
and oral reconstructions subsequent to oral cancer, trauma,
or congenital defects. Both oral mucosa and skin grafts
require harvesting of tissue from secondary sites, resulting
in additional donor site morbidity.2 In addition, because of
their different keratinization patterns, split-thickness skin
grafts frequently may not have acceptable mechanical
properties. They also contain adnexal structures, which
may result in hair formation in the mouth.3 Furthermore,
the limited availability of oral mucosa allows for harvest-
ing only a small graft. As a successful solution to these
limitations, tissue engineering has been applied to the
fabrication of skin and mucosal substitutes.4–8 An example
of such an engineered substitute is the human ex vivo
produced oral mucosa equivalent (EVPOME).2,9–11
EVPOMEs are made from primary human oral keratino-
cytes, which are grown in a serum-free chemically defined
culture medium without a feeder layer on human cadaveric
acellular dermis, AlloDerm. These constructs have excel-
lent handling characteristics. Already, they have been used
in human clinical trial approved by the US Food and Drug
Administration.11
A challenge in the production of tissue-engineered con-
structs is that many or perhaps most of these cell-based
products require continuous real-time monitoring to assess
the cell metabolic function and viability before release for
use in patients. The monitoring is also needed after grafting
into patients.12 Currently, there is a small number of bio-
analytical techniques suitable for such monitoring.13,14 How-
ever, these technologies often require sophisticated specimen
preparation, are expensive, and invasive.
Previously, we reported a rapid and noninvasive Raman
spectroscopic technique for in vitro quality monitoring of
EVPOMEs during manufacturing and postmanufactur-
ing.15,16 In this communication, we demonstrate the use of
Raman spectroscopy for in vivo monitoring of implanted
EVPOMEs into severe combined immunodeficiency (SCID)
mice by means of Raman failure indicators for classifica-
tion of compromised and control EVPOMEs. This nonin-
vasive in vivo monitoring system can assess the quality of
EVPOMEs with minimal user intervention. Because it uses
an existing portable Raman system, it may be translatable to
a clinical setting for use by oral surgeons and operating
room personnel and may provide an efficient and real-time
noninvasive evaluation of grafted tissue constructs.
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Materials and Methods
Oral keratinocyte culture and EVPOME manufacture
Procedures of harvesting human oral mucosal tissue were
approved by the University of Michigan Institutional Re-
view Board. The processes for primary human oral kerati-
nocyte culture and EVPOME manufacturing were detailed
previously.2,10 Briefly, trypsin (Sigma) was used to disso-
ciate primary human oral keratinocytes from tissues, and
keratinocyte cultures were established in a chemically de-
fined culture medium without serum (EpiLife and EDGS;
Invitrogen, Life Technologies) containing 0.06mM calcium,
25 mg/mL gentamicin, and 0.375 mg/mL fungizone. A 1-cm2
acellular cadaver dermis (AlloDerm; LifeCell Corporation)
was presoaked in 0.05 mg/mL human type IV collagen
(Sigma) at 4C overnight and was seeded with 200K oral
keratinocytes to produce EVPOMEs. EVPOMEs were im-
mersed in a medium containing 1.2mM calcium for 4 days
and then for an additional 7 days at an air–liquid phase.
Control EVPOMEs were maintained at 37C. Thermally
stressed samples were kept at 43C overnight on day 9
postseeding for 24 h and switched back to 37C for 24 h
before analysis. One-fifth of EVPOMEs were collected at
the 11th day after cell seeding and fixed in 10% formalin.
The samples were then processed and stained with hema-
toxylin and eosin (H&E) by the histology core at the Uni-
versity of Michigan School of Dentistry. The rest of the
EVPOME samples were surgically implanted into SCID (7-
to 8-week-old) mice.
Mouse surgery for EVPOME grafting
and postimplanted histology
The University of Michigan Committee on Use and Care
of Animals (UCUCA) approved all animal study protocols.
Surgical procedures in our mouse model were detailed in a
previous article.17 Briefly, EVPOMEs were implanted into
7- to 8- week-old SCID mice, strain SCID Hairless Outbred
(Charles River Laboratories International, Inc.). EVPOMEs
were inserted into dorsal subcutaneous pouches for 1 and 3
weeks before in vivo analysis. Mice were anesthetized by
inhalation using isoflurane. Betadine (Purdue Products L.P.)
was applied to disinfect the mice dorsal skin followed
by the injection of analgesic buprenorphine. A 2.0-cm2
subcutaneous pouch was created to accommodate a 1.0-cm2
EVPOME. A slightly larger sterilized 0.005-inch-thick
silicone sheeting (Specialty Manufacturing) was overlaid
on each implanted EVPOME to prevent adherence of the
EVPOME to the mouse tissue. The epidermal side of the
EVPOME, overlaid with cellular layers, was grafted facing
toward the overlaying skin of the pocket. The incision was
closed with the Autoclip (Becton Dickinson). Postimplanted
EVPOMEs were removed from mice after in vivo Raman
spectroscopic analysis. The samples were fixed in 10%
formalin and then processed and stained with H&E by the
histology core at the Dental School, University of Michigan.
For immunohistochemistry, the anti-pan keratin antibody
(ab8068; Abcam) with a dilution of 1:250 was used, and the
signals were detected by DAB Chromagen for 5min with
hematoxylin as counterstaining. Eight mice were used for
each batch of EVPOME grafting: four mice for 1-week
implantation and four for 3-week implantation. Two control
and two thermal stressed EVPOMEs were grafted into SCID
mice for 1 and 3 weeks of implantation, respectively.
Raman probe
We employed a custom-designed Raman fiber-optic
probe system to collect Raman spectra. The system was
detailed previously.18 Briefly, a diode laser (830 nm wave-
length; Innovative Photonic Solutions, Inc.) was used for
excitation. The laser light was sent through a 300-mm core
fiber into a probe head. The probe head contained focusing
optics, which included a number of lenses, mirrors, and
filters that were used to focus the laser beam onto a speci-
men, collect Raman signal, and remove the excitation light
from the collected Raman signal. The incident laser power
was measured to be *120mW at the specimen. Raman
signal was collected by the focusing optics and steered into
a collection fiber bundle, which consisted of 50 fibers
(100mm core diameter). The fibers were arranged into a
circular disc at the probe side and were rearranged into a
linear array for the light to be coupled into an integrated
Raman spectroscopic system (Rxn1; Kaiser Optical Sys-
tems, Inc.). A 50-mm entrance slit was used to obtain the
spectral resolution of 7–8 cm - 1. A HoloSpec Calibration
Accessory (Kaiser Optical Systems, Inc.) was used for cal-
ibration of the wavelength scale of the spectrograph as well
as the wavelength-dependent response of the detector. We
have developed a LabVIEW-based software suite, which
was used for data acquisition and dark subtraction/baseline
adjustment by a modified polyfit method.19 All the post-
processing and data analysis were done by using locally
written LabVIEW/MATLAB scripts.
Data collection and analysis
Spectroscopic measurements were performed on 24 mice.
Before measurements, each mouse was anesthetized. Then,
its dorsolateral skin was opened to expose the subcutane-
ously implanted EVPOME. The silicone sheet was removed.
In general, we collected three spectra for each mouse. The
acquisition time was 5min for each spectrum.
Levenberg–Marquardt algorithm (implemented in Lab-
VIEW) was used to fit the Raman bands. We have per-
formed t-tests to access the ability of Raman metrics to
differentiate between stressed and nonstressed constructs.
Differences were considered significant at p< 0.01. We have
determined a threshold value for the most significant Raman
metrics that gave the best separation between nonstressed
and stressed EVPOMEs. Specificity and sensitivity were
calculated using the standard formula.
Results
Histology analysis of pre- and postimplanted
EVPOMEs
The representative preimplanted EVPOME histology
pictures are shown in Figure 1. The cellular layers were
severely damaged when EVPOMEs were cultured at 43C
for 24 h (Fig. 1, right column). Some residual cells and
keratin could still be observed for these thermal stressed
EVPOMEs. The H&E histology pictures of postimplanted
EVPOMEs are shown in Figure 2. To confirm the pres-
ence of keratin structure on postimplanted EVPOMEs, the
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anti-pan keratin antibody was used and the results are shown
in Figure 3. The epithelial layer continued to stratify and
differentiate at 1 week postimplantation for control EV-
POME (Figs. 2a and 3a, marked with double arrow line). A
much lesser degree of reepithelialization was observed on
the compromised EVPOME at 1 week postimplantation
(Figs. 2b and 3b). At 3 weeks postimplantation, mice cells
gradually infiltrated the EVPOMEs and replaced epithelial
cells and structure on EVPOMEs. However, much more
keratin was left in the control sample due to a higher degree
of reepithelialization (Figs. 2c and 3c) when compared with
the compromised EVPOME (Figs. 2d and 3d), on which
only residual keratin was observed.
In vivo Raman spectra data analysis
Representative Raman spectra of thermal stressed and
nonstressed EVPOMEs (constructs for 1 and 3 weeks
postimplantation) are shown in Figure 4. The phenylala-
nine band was sharp and contained no unresolved com-
ponents, which allowed a relatively straightforward peak
fitting and thus was convenient to use for normalization of
FIG. 1. Representative batch of pre-
implanted H&E histology pictures of control
(a, c) and thermal stressed (b, d) EVPOMEs,
which were subsequently implanted for 1
week (a, b) and 3 weeks (c, d). Thermally
stressed specimens were cultured at 43C
for 24 h. Scaffold AlloDerm areas were
marked with ‘‘A.’’ All scale bars are
100 mm. EVPOMEs, ex vivo produced oral
mucosa equivalent; H&E, hematoxylin and
eosin. Color images available online at
www.liebertpub.com/tec
FIG. 2. Representative batch of
postimplanted H&E histology pic-
tures of control (a, c) and thermal
stressed (b, d) EVPOMEs, which
were implanted for 1 week (a, b)
and 3 weeks (c, d). Thermally
stressed specimens were cultured at
43C for 24 h. Scaffold AlloDerm
areas were marked with ‘‘A.’’
Double arrow lines marked the re-
gions of reepithelialization for 1
week postimplanted controls and
thermal stressed EVPOMEs. The
remaining keratin was marked with
arrows on both control and thermal
stressed 3 weeks postimplanted
EVPOMEs. All scale bars are
100 mm. Color images available
online at www.liebertpub.com/tec
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spectra. Similar to the in vitro measurements,16 amide III
envelope (maximum at 1250 cm - 1) and CH2 deformation
(at 1450 cm - 1) were clearly identifiable in all the spectra.
Multiple overlapping unresolved bands were present in
both the amide bands. As Figure 4 shows, changes in
shape in the amide III band occurred as a result of thermal
stress. The height of CH2 deformation band (relative to
phenylalanine band) also changed. Figure 5 shows the
CH2/phenylalanine band ratios for thermal stressed and
nonstressed EVPOMEs for 1 and 3 weeks postimplanta-
tion. As Figure 5 demonstrates, the metric (previously
developed for the EVPOME constructs investigated
in vitro15) can be used to distinguish between both stressed
and nonstressed constructs ( p < 0.001). There is also a
noticeable change between 1 and 3 weeks postimplanta-
tion EVPOME ( p = 0.002).
Furthermore, we examined the CH2/phenylalanine band
height ratio and determined the threshold values that max-
imize the sensitivity and specificity. By setting the threshold
to 6.2 for 1 week postimplantation EVPOMEs and to 4.7 for
3 weeks postimplantation EVPOMEs, the specimens were
classified with 92% sensitivity and 93% specificity and
FIG. 3. Representative batch of
postimplanted immunohistochem-
istry histology pictures using anti-
pan keratin antibody for control (a,
c) and thermal stressed (b, d) EV-
POMEs, which were implanted for
1 week (a, b) and 3 weeks (c, d).
Thermally stressed specimens were
cultured at 43C for 24 h. Scaffold
AlloDerm areas were marked with
‘‘A.’’ Double arrow lines marked
the regions of reepithelialization
for 1 week postimplanted control
and thermal stressed EVPOMEs.
All scale bars are 100mm. Color
images available online at
www.liebertpub.com/tec
FIG. 4. Raman spectra of thermal stressed and nonstressed EVPOME (implanted in a mouse for 1 and 3 weeks) were
normalized to a phenylalanine (1004 cm - 1) band. Broad amide III band at 1250 cm - 1 and CH2 peak at 1450 cm
- 1 are
clearly visible. Color images available online at www.liebertpub.com/tec
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100% sensitivity and 94% specificity for 1 week and 3
weeks postimplantation, respectively.
Discussion
As reported previously,20 structural changes in both
EVPOME and AlloDerm are caused by thermal stress.
As the histology data suggest, the disruption of a cell
layer was at least partially responsible for the difference
between stressed and nonstressed and preimplantation
EVPOMEs. The intact and healthy keratinocytes on the ep-
ithelial layer of EVPOME could explain the much higher
activity of keratinocytes, both in proliferation and in differ-
entiation in control EVPOMEs compared with the thermal
stressed ones at 1 week postimplantation. This major struc-
ture difference in reepithelialization between the control
and compromised implanted EVPOMEs could cause shape
changes in the amide envelopes as well as the height of the
CH2 deformation band when measured in vivo by Raman
spectra. We also surmise that as the implantation time of
EVPOMEs increased, the host mice cells played more pro-
minent roles than EVPOMEs themselves, resulting in spec-
tral changes we observed. EVPOMEs with healthy and intact
epithelial layers would recruit more host cells to be inter-
graded into and onto grafts and have more epithelial struc-
tures left when compared with compromised or nonhealthy
EVPOMEs at 3 weeks postimplantation. The recruitment of
more host cells was possibly from the secretion of chemo-
kines, such as IL8, by epithelial cells on EVPOMEs. Our
unpublished data indicated that IL8 as a potential candidate
to promote the wound healing process of grafted tissue-en-
gineered constructs. Interestingly, Yoshizawa et al.21 also
observed similar histology results to our postimplantation
EVPOMEs.
The Raman metric, which we originally developed for the
in vitro measurements, can be applied in vivo, as it is ca-
pable of distinguishing between grafted stressed and non-
stressed EVPOME constructs. By using this ratio, we can
determine which constructs are more viable and, thus,
noninvasively monitor the postgrafted outcomes in a real
time. Also, the noticeable change between 1 and 3 weeks
postimplantation EVPOMEs shows that the protein (and
possibly lipid content changes) occurring during the im-
plantation can also be detected.
Conclusion
We have developed a fiber-optic probe to investigate
EVPOME constructs implanted in mice by examining their
Raman spectra. Furthermore, we defined criteria to non-
invasively determine the viability of EVPOMEs in vivo,
which was found to be consistent with the previously re-
ported in vitro data.
Based on these intensity ratios, we developed a Raman
metric and determined its threshold value, at which the
constructs become nonviable. Therefore, by using this
metric, we can judge the viability of EVPOME without
knowing a priori whether or not it was thermally stressed.
We have also determined that, in at least some cases, the
constructs become nonviable before the changes become
visible through histological examination. We conclude that
the observed changes in Raman spectra result primarily
from heat denaturation of proteins in both the EVPOME
constructs and the AlloDerm substrates.
We are now ready to proceed to clinical studies and to
noninvasively monitor the implantation of EVPOMEs in
human patients. Ultimately, if it is possible to detect that the
overall health of a graft appears to be compromised, with
Raman spectroscopy, before it is evident clinically, that is,
color and texture during physical examination, appropriate
therapeutic measures can be taken to salvage the graft be-
fore clinical failure, thus saving the patient the cost and time
to repeat the procedure. The eventual goal of this project is
to design a stand-alone system, which can be used in a
clinical setting by surgeons and operating room personnel.
Such a system will improve graft management and sur-
veillance, thus supporting novel methods for oral and
maxillofacial reconstruction in the future.
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